Novo Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products OAD . Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management NovoSeven R RT , growth hormone therapy, hormone replacement therapy and other products.
Quote | Novo Nordisk A/S (NYSE:NVO)
Last: | $142.98 |
---|---|
Change Percent: | 2.56% |
Open: | $141.69 |
Close: | $142.98 |
High: | $143.37 |
Low: | $139.03 |
Volume: | 5,900,099 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Novo Nordisk A/S (NYSE:NVO)
2024-07-02 11:54:16 ET Shares of Novo Nordisk (NYSE: NVO) were slipping 1.7% lower as of 10:57 a.m. ET on Tuesday, after falling as much as 4.4% earlier in the day. The decline came after USA Today published an opinion piece in which President Joe Biden and independent Senator B...
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
Message Board Posts | Novo Nordisk A/S (NYSE:NVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $NVO News Article - Got $5,000? 2 Unstoppable Stocks to Buy and Hold Forever | whytestocks | investorshangout | 04/20/2023 12:45:49 PM |
whytestocks: $NVO News Article - Why Wegovy and Ozempic Could Be Cash Cows for Novo Nordisk | whytestocks | investorshangout | 04/12/2023 3:45:45 PM |
whytestocks: $NVO News Article - Which Healthcare Company Will Be the First to Get to a $1 Trillion | whytestocks | investorshangout | 04/12/2023 3:40:47 PM |
whytestocks: $NVO News Article - 2 Stocks That Could Be Red-Hot Buys in 2023 | whytestocks | investorshangout | 12/14/2022 7:50:48 PM |
whytestocks: $NVO News Article - Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript | whytestocks | investorshangout | 04/29/2022 4:45:50 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 11:54:16 ET Shares of Novo Nordisk (NYSE: NVO) were slipping 1.7% lower as of 10:57 a.m. ET on Tuesday, after falling as much as 4.4% earlier in the day. The decline came after USA Today published an opinion piece in which President Joe Biden and independent Senator B...
2024-06-30 09:15:00 ET Novo Nordisk (NYSE: NVO) has emerged as one of the biggest names in the pharmaceutical world thanks to its robust line of glucagon-like peptide-1 (GLP-1) medicines. The Danish drugmaker develops Ozempic, Rybelsus, Saxenda, and Wegovy. While Ozempic is appr...
2024-06-29 11:34:00 ET For most of its existence, Altimmune (NASDAQ: ALT) has been a little-known biotech aspiring to compete in a world dominated by whales like Novo Nordisk (NYSE: NVO) , the maker of the hit weight loss drug Wegovy and the blockbuster Ozempic for type 2 di...